Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fuisz Technologies was a pioneering drug delivery company specializing in the development of rapid-dissolve oral dosage forms and other novel delivery systems. Founded by Dr. Richard Fuisz, the company is best known for its proprietary FlashDose technology, which utilizes a unique spinning process to create highly porous, fast-dissolving tablets. The company's innovations significantly improved patient compliance and convenience, particularly for pediatric and geriatric populations. Fuisz Technologies was acquired by Biovail Corporation in 1999, and its technologies have since been licensed to numerous global pharmaceutical companies for blockbuster products. The company's legacy continues through its foundational patents in the fast-dissolve market and the subsequent work of the Fuisz family in the pharmaceutical industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fuisz Technologies.